ANGPTL4通过脱化稳定骨形态遗传蛋白7并通过SMAD/MAPK途径促进HCC的扩散
Yun Bai1, Guanghua Cui1, Xiaoke Sun1
1Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
血管蛋白相关蛋白4 (ANGPTL4) 通过抑制BMP7无处可见性来促进肝细胞癌 (HCC). 骨形态遗传蛋白7 (BMP7) 的过度表达逆转了 ANGPTL4 的作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 肝细胞癌 (HCC) 仍然是一个重大的全球健康挑战.
- 了解推动HCC进展的分子机制对于开发有效疗法至关重要.
- 血管蛋白相关蛋白4 (ANGPTL4) 和骨形态遗传蛋白7 (BMP7) 在HCC中的作用尚未完全阐明.
研究的目的:
- 为了研究ANGPTL4和BMP7在HCC中的功能相互作用.
- 确定 ANGPTL4 影响 BMP7 稳定性和信号的机制.
- 探索针对HCC中的ANGPTL4-BMP7轴的治疗潜力.
主要方法:
- 同时感染HepG2细胞与ANGPTL4和BMP7过度表达等离子体.
- 评估ANGPTL4对BMP7表达和无处不在水平的影响.
- 在体外和体内实验涉及ANGPTL4淘汰和BMP7过度表达的实验.
- 下游信号通路的分析,包括Smad1/5/8和MAPK14.
主要成果:
- ANGPTL4 直接与 BMP7.7 相互作用.
- 抑制ANGPTL4会导致BMP7的表达增加和无处不在.
- 过度表达BMP7可以抵消ANGPTL4对HCC增殖和迁移的抑制作用.
- 抑制ANGPTL4降低了Smad1/5/8和MAPK14的表达,而BMP7过度表达反转了这种情况.
结论:
- ANGPTL4通过抑制BMP7的无化和降解来促进HCC的扩散和迁移.
- ANGPTL4-BMP7相互作用会影响Smad/MAPK信号通路.
- 针对ANGPTL4-BMP7轴为HCC提供了一个新的治疗策略.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
相关概念视频
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
